Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01496573 · ClinicalTrials.gov registry record
Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma
A clinical trial of Childhood Rhabdomyosarcoma and Alveolar Childhood Rhabdomyosarcoma, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 77
- Enrollment target
- 1
- Study location
NCT01496573: Completed study of Childhood Rhabdomyosarcoma and Alveolar Childhood Rhabdomyosarcoma, sponsored by Children's Oncology Group.
NCT01496573 is a study of Childhood Rhabdomyosarcoma and Alveolar Childhood Rhabdomyosarcoma that has completed, run by Children's Oncology Group. The registered enrollment target is 77 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01496573, a study of Childhood Rhabdomyosarcoma and Alveolar Childhood Rhabdomyosarcoma, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 77 participants
- Enrollment target
- 1
- Study location
Study Summary
This research trial studies biomarkers in tumor tissue samples from younger patients with rhabdomyosarcoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
Study Locations (1)
California
- Children's Oncology Group - Monrovia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2011-12 |
| Est. Completion | 2016-05 |
What the finished NCT01496573 record still lists
NCT01496573 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 77 participants, a relatively small participant target.
The record links to 3 conditions, with Childhood Rhabdomyosarcoma appearing as the primary indexed condition, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT01496573 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01496573 about?
NCT01496573 is a clinical study titled "Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma". This research trial studies biomarkers in tumor tissue samples from younger patients with rhabdomyosarcoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer
What is the current status of trial NCT01496573?
This trial is currently completed. The enrollment target is 77 participants. The study started on 2011-12. Estimated completion is 2016-05.
What conditions does trial NCT01496573 study?
This clinical trial studies the following conditions: Childhood Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma.
What interventions are being tested in trial NCT01496573?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT01496573?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01496573 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Rhabdomyosarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia